198 related articles for article (PubMed ID: 1581231)
1. Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.
Habermann TM; Andersen JW; Cassileth PA; Bennett JM; Oken MM
Br J Haematol; 1992 Apr; 80(4):466-71. PubMed ID: 1581231
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study.
Martin A; Nerenstone S; Urba WJ; Longo DL; Lawrence JB; Clark JW; Hawkins MJ; Creekmore SP; Smith JW; Steis RG
J Clin Oncol; 1990 Apr; 8(4):721-30. PubMed ID: 2313337
[TBL] [Abstract][Full Text] [Related]
3. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.
Seymour JF; Talpaz M; Kurzrock R
Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417
[TBL] [Abstract][Full Text] [Related]
4. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
5. Role of interferon-alpha administration after 2-deoxycoformycin in the treatment of hairy cell leukemia patients.
Marotta G; Frassoldati A; Zinzani P; Annino L; Brugiatelli M; Ambrosetti A; Lenoci M; Federico M; Foa R; Lauria F;
Eur J Haematol; 2006 Aug; 77(2):109-13. PubMed ID: 16856905
[TBL] [Abstract][Full Text] [Related]
6. Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
Ho AD; Thaler J; Mandelli F; Lauria F; Zittoun R; Willemze R; McVie G; Marmont AM; Prümmer O; Stryckmans P
J Clin Oncol; 1989 Oct; 7(10):1533-8. PubMed ID: 2789273
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of hair cell leukemia with 2'-deoxycoformycin after failure of interferons alpha or beta.
Dutcher JP; Salva KM; Wiernik PH
Am J Clin Oncol; 1990 Aug; 13(4):290-3. PubMed ID: 2198792
[TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.
Grever M; Kopecky K; Foucar MK; Head D; Bennett JM; Hutchison RE; Corbett WE; Cassileth PA; Habermann T; Golomb H
J Clin Oncol; 1995 Apr; 13(4):974-82. PubMed ID: 7707126
[TBL] [Abstract][Full Text] [Related]
9. [Hairy cell leukemia successfully treated with 2'-deoxycoformycin following refractoriness to splenectomy and alpha-interferon therapy].
Shibata T; Hotta T
Rinsho Ketsueki; 1992 Feb; 33(2):216-20. PubMed ID: 1635172
[TBL] [Abstract][Full Text] [Related]
10. Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a.
Berman E; Heller G; Kempin S; Gee T; Tran LL; Clarkson B
Blood; 1990 Feb; 75(4):839-45. PubMed ID: 2302457
[TBL] [Abstract][Full Text] [Related]
11. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
Smith JW; Longo DL; Urba WJ; Clark JW; Watson T; Beveridge J; Conlon KC; Sznol M; Creekmore SP; Alvord WG
Blood; 1991 Oct; 78(7):1664-71. PubMed ID: 1912555
[TBL] [Abstract][Full Text] [Related]
12. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
[TBL] [Abstract][Full Text] [Related]
13. Deoxycoformycin in the treatment of patients with hairy cell leukemia: results of a Spanish collaborative study of 80 patients.
Rafel M; Cervantes F; Beltrán JM; Zuazu F; Hernández Nieto L; Rayón C; García Talavera J; Montserrat E
Cancer; 2000 Jan; 88(2):352-7. PubMed ID: 10640967
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients.
Maloisel F; Benboubker L; Gardembas M; Coiffier B; Divine M; Sebban C; Blanc M; Abgrall JF; Lederlin P; Harousseau JL; Blaise AM; Grosbois B; Morice P; Ghandour C; Castaigne S
Leukemia; 2003 Jan; 17(1):45-51. PubMed ID: 12529659
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
Glaspy JA; Souza L; Scates S; Narachi M; Blatt L; Ambersley J; Golde DW
J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
[TBL] [Abstract][Full Text] [Related]
17. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
Ho AD; Kuse R; Prümmer O; Porzsolt F; Hunstein W
Klin Wochenschr; 1987 Oct; 65(20):975-9. PubMed ID: 3501501
[TBL] [Abstract][Full Text] [Related]
18. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
Golomb HM; Dodge R; Mick R; Budman D; Hutchison R; Horning SJ; Schiffer CA
Leukemia; 1994 Dec; 8(12):2037-40. PubMed ID: 7807991
[TBL] [Abstract][Full Text] [Related]
19. Response to 2'-deoxycoformycin after failure of interferon-alpha in nonsplenectomized patients with hairy cell leukemia.
Foon KA; Nakano GM; Koller CA; Longo DL; Steis RG
Blood; 1986 Jul; 68(1):297-300. PubMed ID: 3487358
[TBL] [Abstract][Full Text] [Related]
20. Pentostatin induces durable remissions in hairy cell leukemia.
Cassileth PA; Cheuvart B; Spiers AS; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
J Clin Oncol; 1991 Feb; 9(2):243-6. PubMed ID: 1988572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
